Securian Asset Management Inc. Sells 1,101 Shares of HCA Healthcare, Inc. $HCA

Securian Asset Management Inc. decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,955 shares of the company’s stock after selling 1,101 shares during the quarter. Securian Asset Management Inc.’s holdings in HCA Healthcare were worth $3,390,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in HCA. Abound Wealth Management grew its position in HCA Healthcare by 28.0% in the third quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after acquiring an additional 26 shares in the last quarter. ORG Partners LLC boosted its holdings in shares of HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares during the period. Glenview Trust co raised its holdings in HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock valued at $501,000 after buying an additional 32 shares during the period. Optas LLC boosted its stake in HCA Healthcare by 4.5% during the third quarter. Optas LLC now owns 760 shares of the company’s stock worth $324,000 after buying an additional 33 shares during the period. Finally, Sivia Capital Partners LLC raised its stake in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $470.23 on Thursday. The company’s 50-day simple moving average is $479.37 and its two-hundred day simple moving average is $426.03. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $520.00. The company has a market capitalization of $107.30 billion, a price-to-earnings ratio of 18.18, a price-to-earnings-growth ratio of 1.33 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same period last year, the company posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 29th. Shareholders of record on Monday, December 15th were paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s payout ratio is 11.13%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Mizuho boosted their price objective on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. KeyCorp lifted their target price on HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Barclays raised their price target on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. Finally, Jefferies Financial Group upped their target price on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $485.95.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.